| Revenues | 8,665a | 8,046a |
| Cost of sales | -6,880a | -6,415a |
| Gross margin | 1,785a | 1,631a |
| SG&A | -478a | -447a |
| R&D | -361a | -373a |
| Other expense (income) | 63a | 15a |
| Restructuring charges (reversals) | -3a | -1a |
| Loss (gain) related to disposal of business | 0a | -81a |
| Impairment and program termination (reversals) | -2a | -83a |
| EBIT | 878a | 793a |
| Financing expense | -677a | -594a |
| Financing income | -55a | -202a |
| EBT | 256a | 401a |
| Income taxes (recovery) | -114a | -89a |
| Net income (loss) from continuing operations | 370a | 490a |
| Net income (loss) from discontinued operations | 0a | -45a |
| Net income | 370a | 445a |